Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1480233
European Journal of Endocrinology, Vol 148, Issue 2, 233-236
Copyright © 2003 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luisi, S
Right arrow Articles by Petraglia, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luisi, S
Right arrow Articles by Petraglia, F

Articles

Maternal serum inhibin A levels are a marker of a viable trophoblast in incomplete and complete miscarriage

S Luisi, P Florio, D D'Antona, FM Severi, F Sanseverino, S Danero, and F Petraglia

Chair of Obstetrics and Gynecology, Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, Siena, Italy.

OBJECTIVE: From early gestation the human trophoblast secretes large amounts of inhibin A and activin A, and their measurement provides a value for predicting the outcome in women who become pregnant after assisted reproductive techniques. The aim of the study was to investigate the putative role of maternal serum inhibin A and activin A levels as markers of a viable trophoblast in women who miscarry. DESIGN: Controlled cross-sectional study. METHODS: One group consisted of 65 healthy pregnant women (controls), progressing to deliver a healthy singleton baby and another group consisted of 54 miscarriages (38 incomplete (27 non-viable, 11 anembryonic pregnancies) and 16 complete). Maternal blood samples were collected between 5 and 12 weeks of gestation. RESULTS: Serum human chorionic gonadotrophin concentrations in women with incomplete or complete miscarriages were significantly (both P<0.001) lower than in controls; activin A levels being lowest only in women with a complete miscarriage (P<0.001). On the other hand, inhibin A levels were significantly lower in incomplete or complete miscarriage than in controls (both P<0.0001). CONCLUSIONS: Maternal serum inhibin A, but not activin A, determination reflects the lack of a viable trophoblast in complete miscarriage.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
P. Florio, F. M. Severi, C. Bocchi, S. Luisi, M. Mazzini, S. Danero, M. Torricelli, and F. Petraglia
Single Serum Activin A Testing to Predict Ectopic Pregnancy
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1748 - 1753.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
S. Luisi, P. Florio, F. M. Reis, and F. Petraglia
Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy
Hum. Reprod. Update, March 1, 2005; 11(2): 123 - 135.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Muttukrishna, C. Bearfield, J. Johns, and E. Jauniaux
Inhibin, activin, follistatin, activin receptors and {beta}-glycan gene expression in the villous tissue of miscarriage patients
Mol. Hum. Reprod., November 1, 2004; 10(11): 793 - 798.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 European Society of Endocrinology.